Skip to main content
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. — Investor Relations & Filings

Ticker · VVOS ISIN · US92859E1082 US Manufacturing
Filings indexed 260 across all filing types
Latest filing 2024-08-14 Interim / Quarterly Rep…
Country US United States of America
Listing US VVOS

About Vivos Therapeutics, Inc.

https://vivos.com/

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for sleep-disordered breathing, including obstructive sleep apnea (OSA). The company's core offering is The Vivos System, a non-surgical treatment that uses proprietary oral appliances. These devices are designed to address underlying dentofacial abnormalities that can restrict the airway. The treatment protocol aims to promote the natural growth and development of the jaw and airway in both adult and pediatric patients. Vivos provides its technology and training to a network of licensed dentists and medical professionals who deliver the therapy.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2024
Interim / Quarterly Report Q2 2024
2024-08-14 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 100% confidence The document is a prospectus filed pursuant to Rule 424(b)(1) related to the resale of common stock and warrants by a selling stockholder. It includes detailed information about the securities offered, risk factors, use of proceeds, selling stockholder, plan of distribution, legal matters, and other disclosures typical of a prospectus. The document is not an annual or quarterly report, earnings release, or management discussion. It is a registration document related to securities offering and resale, which fits the definition of a Capital/Financing Update. The length and content confirm it is a full prospectus, not just an announcement or a brief summary. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2024-08-08 English
Regulatory Filings 2024
Regulatory Filings
2024-08-08 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 95% confidence The document is a letter from the CEO of Vivos Therapeutics, Inc. to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. This is related to a capital raising or securities offering process. The document is short (1130 characters) and is a formal communication about a financing registration statement, not a financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2024-08-05 English
Regulatory Filings 2024
Regulatory Filings Classification · 90% confidence The provided document text appears to be heavily encoded or encrypted, containing no readable or meaningful content related to financial reporting, regulatory bodies, form names, fiscal periods, or document titles. It does not contain any identifiable keywords or phrases that would allow classification into any specific filing category. Given the lack of discernible information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for miscellaneous or unclear filings.
2024-08-02 English
Capital/Financing Update 2024
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC by Vivos Therapeutics, Inc. It is a registration statement under the Securities Act of 1933, used for registering securities for sale to the public. The text includes details about the securities being registered, the selling stockholder, and legal disclaimers. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to securities registration and offering. Therefore, it fits best under the category Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.